Goldman Sachs
ERB

Goldman Sachs’s ERBA DIAGNOSTICS ERB Stock Holding History

Goldman Sachs’s Portfolio ERB Stock Details ERB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-11,879
Closed -$26K – 7659
2015
Q2 		$26K Buy
+11,879
New +$35.4K ﹤0.01% 7038

Other funds holding ERB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs's ERB Position: Q3 2015 in Review

Goldman Sachs sold out of ERBA DIAGNOSTICS (ERB) in Q3 2015, closing a stake of 11,879 shares — an estimated $26K sold.

Goldman Sachs first reported a position in ERB in Q2 2015 and held it in 1 quarter. The position peaked at $26K in Q2 2015. 13 funds tracked by Wall St. Rank hold ERB as of Q3 2015.

  • Goldman Sachs reported no remaining ERBA DIAGNOSTICS position as of Q3 2015 after selling out during the quarter.
  • Goldman Sachs sold 11,879 ERBA DIAGNOSTICS shares in Q3 2015, an estimated $26K.
  • Goldman Sachs first reported a position in ERBA DIAGNOSTICS in Q2 2015 and held it in 1 quarter.
  • Goldman Sachs's ERBA DIAGNOSTICS position peaked at $26K in Q2 2015.
  • 13 funds tracked by Wall St. Rank held ERBA DIAGNOSTICS as of Q3 2015.

Based on Goldman Sachs's 13F filing for Q3 2015, filed 13 Nov 2015.